Analysts Set Cooper Companies Target Price at $90.79

The medical device company's stock receives a 'Moderate Buy' rating from analysts.

Apr. 7, 2026 at 5:57am

Got story updates? Submit your updates here. ›

An extreme close-up of complex, metallic medical device components and machinery, dramatically lit to convey a sense of industrial power and precision without using any text or symbols.Intricate medical equipment and manufacturing processes power Cooper Companies' leadership in vision care and women's health products.San Ramon Today

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have been given a consensus rating of 'Moderate Buy' by the seventeen analysts covering the company, according to Marketbeat. The average 12-month price target among analysts who have covered the stock in the last year is $90.79.

Why it matters

Cooper Companies is a major player in the vision care and women's health products markets, so analyst sentiment and price targets for the stock can provide insights into the company's performance and outlook within those industries.

The details

The analysts' ratings for Cooper Companies include one sell recommendation, seven hold recommendations, eight buy recommendations, and one strong buy recommendation. Several research firms have recently adjusted their price targets for the stock, with Needham & Company LLC raising their target from $99 to $101 and Barclays increasing their target from $98 to $103.

  • Cooper Companies last posted quarterly earnings results on March 5, 2026.

The players

The Cooper Companies, Inc.

A global medical device company headquartered in San Ramon, California that develops, manufactures, and markets vision care and women's health products.

Needham & Company LLC

An investment banking and asset management firm that covers Cooper Companies and recently raised their price target for the stock.

Barclays

A multinational investment bank that also covers Cooper Companies and increased their price target for the stock.

Got photos? Submit your photos here. ›

The takeaway

The mixed analyst sentiment and price targets for Cooper Companies suggest the medical device firm faces both opportunities and challenges in its core vision care and women's health markets, which will be important to monitor going forward.